Husky acquires Sch?ttli

Husky Injection Molding Systems has entered into an agreement to acquire Sch?ttli Group of Diessenhofen, Switzerland, recognized as a global leader in medical and closure mold making. The sale is expected to close in early December.

Sch?ttli is a global leader in a number of select medical applications, such as syringes, infusion/transfusion products, diagnostic systems and feminine care items. Husky hot runner customers will benefit from product improvements based on strengthened knowledge, and existing Sch?ttli customers will have more streamlined access to Husky’s hot runner, controller and injection molding machine products. In addition, Sch?ttli’s closures business complements Husky’s existing closures business by providing additional technology and capacity in both established and growing markets.

Husky has enjoyed a strong and long-lasting relationship with Sch?ttli and has shared a mutual commitment to quality, technology innovation and customer satisfaction, according to John Galt, Husky’s President and CEO. With the acquisition, Husky aims to work  with many skilled people at Sch?ttli as one team to deliver more value to customers, particularly in the medical and closures markets. By bringing Husky and Sch?ttli together, customers will benefit from an enhanced level of technical expertise to produce the highest quality parts, the additional capacity to increase speed to market, and improved responsiveness delivered by the industry’s largest global service and support network.

Following the close of this transaction, Sch?ttli’s headquarters in Diessenhofen, Switzerland, as well as other facilities in San Dimas, California and Suzhou, China, will become part of Husky’s global network of locations.